NCT01134549View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 9, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Hyperparathyroidism, Secondary
Interventions
DRUG

Etelcalcetide

Administered as a single intravenous (IV) injection

DRUG

Placebo

Administered as a single intravenous (IV) injection

Trial Locations (1)

Unknown

Melbourne

Sponsors

Collaborators (1)

Nucleus Network Ltd
All Listed Sponsors
collaborator

Nucleus Network Ltd

OTHER

lead

KAI Pharmaceuticals

INDUSTRY